Summary of Recent Cervical Cancer Screening Guidelines (ACS & HRSA)
Here’s a breakdown of the updated cervical cancer screening guidelines from the American Cancer Society (ACS) and the Health Resources & services Management (HRSA), based on the provided text:
Key Recommendations (Where they agree):
* age Range: Both organizations recommend screening for people with a cervix aged 30-65.
* Primary Test Preference: Both prefer HPV primary testing (testing for high-risk HPV types that cause most cervical cancers) over co-testing (HPV test + Pap test).
* Self-collection: Both accept self-collected HPV tests as a valid choice to provider-collected samples, especially for those with access barriers or discomfort with speculum exams.
* Screening End Point: Screening can generally end at age 65 with a history of normal test results.
Follow-up Frequency (Based on Test & Collection Method):
* HPV Primary/Co-testing (Provider-Collected): Rescreen in 5 years if results are normal.
* HPV Self-Collected: Rescreen in 3 years if results are normal (ACS proposal only – HRSA doesn’t specify).
* Pap Test Alone: Rescreen in 3 years if results are normal.
* Abnormal Results: More frequent screening will be needed.
Key Differences Between Guidelines:
* Starting Age:
* ACS: Recommends starting screening at age 25.
* HRSA: Recommends Pap tests every 3 years from age 21-29,then switching to HPV primary testing or co-testing at age 30.
* Past Results for Ending Screening: ACS is more specific, requiring a decade of normal results (negative HPV tests at 60 & 65, or 3 consecutive negative Pap tests with the last at 65) to stop screening at 65. HRSA is less specific.
What This Means for Patients:
* Test Availability: The test offered will likely depend on what your provider offers. Expect a potential shift towards HPV primary testing.
* Insurance Coverage: HRSA guidelines influence insurance coverage, with most plans required to cover recommended testing and follow-up without copays (starting in 2027).
* Increased Access: Self-collection options will expand screening access to primary care offices, urgent care clinics, mobile clinics, pharmacies, and even at-home collection.
* Importance of Regular Screening: The most important takeaway is to get screened for cervical cancer regularly.
You can find more details at these links provided in the text:
* https://www.ashasexualhealth.org/what-you-need-to-know-about-the-hpv-self-collection-test/
* https://www.ashasexualhealth.org/hpv-cervical-cancer/
Worth a look